The historical data trend for Pila Pharma AB's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:PILA vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, Pila Pharma AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pila Pharma AB Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pila Pharma AB's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Pila Pharma AB's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pila Pharma AB (OSTO:PILA) has a Buyback Yield % of -49.99 as of Jul. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pila Pharma AB and its competitors. According to the industry distribution chart, Pila Pharma AB ranks #619 out of 742 companies in the Biotechnology industry, placing it in the top 83.4%.
Is Pila Pharma AB's Buyback Yield % too high?
Pila Pharma AB's current Buyback Yield % is -49.99. Based on the distribution chart, Pila Pharma AB ranks #619 out of 742 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pila Pharma AB has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pila Pharma AB's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pila Pharma AB ranks #619 out of 742 companies for Buyback Yield %. This places Pila Pharma AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pila Pharma AB and its competitors. Pila Pharma AB's current Buyback Yield % is -49.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pila Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Pila Pharma AB (OSTO:PILA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.83, compared to a current price of kr1.31 — trading 28.4% below its estimated fair value. The current Buyback Yield % is -49.99. Pila Pharma AB's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Pila Pharma AB (OSTO:PILA), the current Buyback Yield % is -49.99 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pila Pharma AB (OSTO:PILA) Overvalued in 2026?
Based on GuruFocus' analysis, Pila Pharma AB stock appears to be undervalued.
The current stock price of kr1.31 is trading 28.4% below its estimated GF Value™ of kr1.83.
GuruFocus considers Pila Pharma AB to be Modestly Undervalued.
Key valuation signals for OSTO:PILA:
Buyback Yield %: -49.99
GF Value™: kr1.83 vs. price of kr1.31 (28.4% below fair value)
No single metric tells the full story. See the OSTO:PILA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
49GF Score
Get the complete analysis for OSTO:PILA
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:PILA has been successfully added to your 
